The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEvraz Regulatory News (EVR)

  • This share is currently suspended. It was suspended at a price of 82.52

Share Price Information for Evraz (EVR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 82.52
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 82.52
EVR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of AGM

18 Jun 2019 13:33

RNS Number : 6484C
Evraz Plc
18 June 2019
 

 

EVRAZ plc (the "Company")

 

Results of the Annual General Meeting

 

The Annual General Meeting (the "Meeting") of the Company was held on Tuesday 18 June 2019 at 11.00am (London time). At the Meeting, the ordinary and special resolutions set out in the Notice of the Annual General Meeting dated 3 May 2019 (the "Notice of AGM"), were proposed and passed by way of a poll. Resolutions 1 to 14 were passed as ordinary resolutions. Resolutions 15 to 18 were passed as special resolutions.

 

Full details of the poll results are set out below and will also be available on the Company's website www.evraz.com.

No 

RESOLUTION

VOTESFOR

%

VOTESAGAINST

%

TOTAL VOTES 

% of ISC VOTED

VOTESWITHHELD

1

To receive the Directors' report and the accounts for the

Company for the year ended 31 December 2018

1,179,677,802

99.86

1,644,619

0.14

1,181,322,421

81.36

347,138

2

To approve the Annual Remuneration Report set out on

pages 120 to 127 of the Annual Report and Accounts 2018

1,128,595,317

95.51

53,060,034

4.49

1,181,655,351

81.39

14,208

3

To re-elect Alexander Abramov as a Director.

1,134,381,221

96.00

47,274,040

4.00

1,181,655,261

81.39

14,298

4

To re-elect Alexander Frolov as a Director.

1,174,615,272

99.40

7,039,990

0.60

1,181,655,262

81.39

14,298

5

To re-elect Eugene Shvidler as a Director.

1,152,861,499

97.56

28,793,763

2.44

1,181,655,262

81.39

14,298

6

To re-elect Eugene Tenenbaum as a Director.

1,172,688,883

99.24

8,966,379

0.76

1,181,655,262

81.39

14,298

7

To elect Laurie Argo as a Director

1,181,607,220

100.00

48,042

0.00

1,181,655,262

81.39

14,298

7*

To elect Laurie Argo as a Director

317,528,948

99.98

48,042

0.02

317,576,990

54.03

14,298

8

To re-elect Karl Gruber as a Director.

1,177,056,904

99.61

4,598,357

0.39

1,181,655,261

81.39

14,298

8*

To re-elect Karl Gruber as a Director.

312,978,632

98.55

4,598,357

1.45

317,576,989

54.03

14,298

9

To re-elect Deborah Gudgeon as a Director.

1,180,046,855

99.86

1,608,407

0.14

1,181,655,262

81.39

14,298

9*

To re-elect Deborah Gudgeon as a Director

315,968,583

99.49

1,608,407

0.51

317,576,990

54.03

14,298

10

To re-elect Alexander Izosimov as a Director.

1,137,934,204

96.30

43,721,057

3.70

1,181,655,261

81.39

14,298

10*

To re-elect Alexander Izosimov as a Director.

273,855,932

86.23

43,721,057

13.77

317,576,989

54.03

14,298

11

To re-elect Sir Michael Peat as a Director.

1,139,814,114

96.47

41,750,040

3.53

1,181,564,154

81.38

105,405

11*

To re-elect Sir Michael Peat as a Director.

275,735,842

86.85

41,750,040

13.15

317,485,882

54.01

105,405

12

To re-appoint Ernst & Young LLP as auditors of the Company.

1,180,896,162

99.95

627,322

0.05

1,181,523,484

81.38

146,074

13

To authorise the Audit Committee of the Company to fix the remuneration of the auditors

1,179,270,785

99.80

2,385,120

0.20

1,181,655,905

81.39

13,654

14

To authorise the Directors to allot shares.

1,172,242,120

99.20

9,413,786

0.80

1,181,655,906

81.39

13,654

15

To authorise the Directors to allot shares wholly for cash.

1,178,475,893

99.73

3,178,298

0.27

1,181,654,191

81.39

15,369

16

To authorise the Directors to allot shares wholly for cash

and used only for financing acquisitions or capital

investments.

1,178,086,024

99.70

3,568,166

0.30

1,181,654,190

81.39

15,369

17

To authorise the Company to buy back shares.

1,167,252,998

98.95

12,423,380

1.05

1,179,676,378

81.25

1,993,181

18

To authorise the Directors to call a general meeting other than an annual general meeting on not less than 14 clear days' notice

1,168,066,142

98.85

13,589,764

1.15

1,181,655,906

81.39

13,654

* Result of poll of independent shareholders only.

Notes:

1. Any proxy arrangement which gave discretion to the Chairman has been included in the "for" totals.

2. A "vote withheld" is not a vote under English law and is not counted in the calculation of the proportion of votes "for" or "against" a resolution.

3. The issued share capital of EVRAZ plc as at 18 June 2019 is 1,506,527,294 ordinary shares. The Company holds 54,619,521 ordinary shares in treasury. The total number of voting rights attaching to the ordinary shares of the Company is therefore 1,451,907,773.

4. The scrutineer of the poll was Computershare Investor Services PLC.

5. All percentages are rounded to two decimal points.

In accordance with Listing Rule 9.6.2, a copy of the resolutions passed at the Meeting will shortly be available for inspection on the National Storage Mechanism which can be accessed at http://www.morningstar.co.uk/uk/NSM

 

 

 

For further information:

Media Relations:

Investor Relations:

 

Mariya Starovoyt

Director, External communications

London: +44 207 832 8998 Moscow: +7 495 937 6871

media@evraz.com

Irina Bakhturina

Director, Investor Relations

London: +44 207 832 8990 Moscow: +7 495 232 1370

ir@evraz.com

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
RAGSFSFEAFUSEEM
Date   Source Headline
28th Feb 20237:00 amEQSDISCONTINUATION OF DISCLOSURE VIA PRIMARY INFORMATION PROVIDER
27th Feb 20237:00 amEQSCLARIFICATION ON ANNUAL REPORT AND AUDITED FINANCIAL STATEMENTS FOR 2022
28th Dec 20228:30 amEQSEVRAZ plc announces that the Appointment and the Amendments adopted as part of the Consent Solicitation for its outstanding U.S.$700,000,000 5.250 per cent. notes due 2024 have become effective
28th Dec 20227:30 amEQSEVRAZ plc announces that the Appointment and the Amendments adopted as part of the Consent Solicitation for its outstanding U.S.$700,000,000 5.250 per cent. notes due 2024 have become effective
23rd Dec 20228:30 amEQSEVRAZ plc announces results of the Consent Solicitation for its outstanding U.S.$700,000,000 5.250 per cent. notes due 2024
23rd Dec 20227:30 amEQSEVRAZ plc announces results of the Consent Solicitation for its outstanding U.S.$700,000,000 5.250 per cent. notes due 2024
19th Dec 202212:00 pmEQSEVRAZ plc announces that the Appointment and the Amendments adopted as part of the Consent Solicitation for its outstanding notes due 2023 have become effective
19th Dec 202211:00 amEQSEVRAZ plc announces that the Appointment and the Amendments adopted as part of the Consent Solicitation for its outstanding notes due 2023 have become effective
8th Dec 20229:17 amEQSEVRAZ plc announces results of the Consent Solicitation for its outstanding U.S.$750,000,000 5.375 per cent. notes due 2023
8th Dec 20229:15 amEQSNOTICE OF ADJOURNED MEETING to the holders of outstanding U.S.$700,000,000 5.250 per cent. notes due 2024 issued by the Issuer
8th Dec 20228:17 amEQSEVRAZ plc announces results of the Consent Solicitation for its outstanding U.S.$750,000,000 5.375 per cent. notes due 2023
8th Dec 20228:16 amEQSNOTICE OF ADJOURNED MEETING to the holders of outstanding U.S.$700,000,000 5.250 per cent. notes due 2024 issued by the Issuer
15th Nov 20228:10 amEQSEVRAZ plc announces Consent Solicitation in respect of its outstanding U.S.$750,000,000 5.375 per cent. notes due 2023
15th Nov 20228:10 amEQSEVRAZ plc announces Consent Solicitation in respect of its outstanding U.S.$700,000,000 5.250 per cent. notes due 2024
15th Nov 20227:10 amEQSEVRAZ plc announces Consent Solicitation in respect of its outstanding U.S.$750,000,000 5.375 per cent. notes due 2023
15th Nov 20227:10 amEQSEVRAZ plc announces Consent Solicitation in respect of its outstanding U.S.$700,000,000 5.250 per cent. notes due 2024
9th Nov 20221:45 pmEQSEVRAZ plc: ERNST & YOUNG TERMINATED ITS SERVICES FOR EVRAZ PLC
9th Nov 202212:46 pmEQSEVRAZ plc: ERNST & YOUNG TERMINATED ITS SERVICES FOR EVRAZ PLC
2nd Nov 20222:56 pmEQSEVRAZ plc: SANCTIONS IMPOSED ON MR. ABRAMOV AND MR. FROLOV
2nd Nov 20221:56 pmEQSEVRAZ plc: SANCTIONS IMPOSED ON MR. ABRAMOV AND MR. FROLOV
20th Oct 20227:45 pmEQSEVRAZ plc: EVRAZ SANCTIONED IN NEW ZEALAND
20th Oct 20227:45 pmEQSEVRAZ plc: EVRAZ SANCTIONED IN NEW ZEALAND
14th Oct 20224:35 pmEQSEVRAZ plc: CHANGES IN THE COMPOSITION OF THE BOARD OF DIRECTORS
14th Oct 20224:35 pmEQSEVRAZ plc: CHANGES IN THE COMPOSITION OF THE BOARD OF DIRECTORS
3rd Oct 202212:14 pmEQSEVRAZ plc: CHANGES IN THE COMPOSITION OF THE BOARD OF DIRECTORS
3rd Oct 202212:14 pmEQSEVRAZ plc: CHANGES IN THE COMPOSITION OF THE BOARD OF DIRECTORS
16th Sep 20226:45 pmEQSEVRAZ plc: UPDATE ON PAYMENT OF INTEREST DUE ON EUROBONDS ISSUED BY EVRAZ PLC
16th Sep 20226:45 pmEQSEVRAZ plc: UPDATE ON PAYMENT OF INTEREST DUE ON EUROBONDS ISSUED BY EVRAZ PLC
16th Sep 202210:24 amEQSEVRAZ plc: Changes in the composition of the Board of Directors
16th Sep 202210:24 amEQSEVRAZ plc: Changes in the composition of the Board of Directors
10th Aug 20224:00 pmEQSEVRAZ is launching soliciting of proposals for its North American subsidiaries acquisition
10th Aug 20224:00 pmEQSEVRAZ is launching soliciting of proposals for its North American subsidiaries acquisition
4th Aug 20227:39 amEQSEVRAZ plc: UNAUDITED INTERIM FINANCIAL RESULTS FOR H1 2022U
4th Aug 20227:37 amEQSEVRAZ plc: UNAUDITED INTERIM FINANCIAL RESULTS FOR H1 2022U
2nd Aug 20228:00 amEQSEVRAZ plc: NOTICE OF H1 2022 RESULTS AND CONFERENCE CALL DETAILS
2nd Aug 20228:00 amEQSEVRAZ plc: NOTICE OF H1 2022 RESULTS AND CONFERENCE CALL DETAILS
28th Jul 20222:33 pmEQSEVRAZ plc: Important notice to noteholders
28th Jul 20222:32 pmEQSEVRAZ plc: Important notice to noteholders
25th Jul 20224:22 pmEQSEVRAZ plc: SPECIAL LICENCE FOR EUROBONDS COUPON PAYMENTS REQUESTED
25th Jul 20224:22 pmEQSEVRAZ plc: SPECIAL LICENCE FOR EUROBONDS COUPON PAYMENTS REQUESTED
21st Jul 20226:15 pmEQSEVRAZ plc: Response to press speculations
21st Jul 20226:15 pmEQSEVRAZ plc: Response to press speculations
18th Jul 20228:39 amEQSEVRAZ plc: Termination of the registry and associated services
18th Jul 20228:38 amEQSEVRAZ plc: Termination of the registry and associated services
30th Jun 20221:55 pmEQSEVRAZ plc: Results of the Annual General Meeting
30th Jun 20221:55 pmEQSEVRAZ plc: Results of the Annual General Meeting
28th Jun 20223:45 pmEQSEVRAZ plc publishes its Modern Slavery Act Transparency Statement for 2021
28th Jun 20223:45 pmEQSEVRAZ plc publishes its Modern Slavery Act Transparency Statement for 2021
17th Jun 20226:57 pmEQSEVRAZ plc: EVRAZ HAS RECEIVED A SPECIAL LICENCE FROM OFSI FOR AGM2022
17th Jun 20226:57 pmEQSEVRAZ plc: EVRAZ HAS RECEIVED A SPECIAL LICENCE FROM OFSI FOR AGM2022

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.